Recruiting OBSERVATIONAL NCT06982794
A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma (Urolife)
'UROLIFE': a Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma
Sponsor: IRCCS San Raffaele
Conditions
Urothelial Carcinoma (UC)
Updated 1 time since 2025 Last updated: May 13, 2025 Started: Jun 30, 2025 Primary completion: Sep 30, 2025 Completion: Oct 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Urothelial Carcinoma (UC) and is currently actively recruiting participants. IRCCS San Raffaele leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- IRCCS San Raffaele
Data source: IRCCS San Raffaele
For direct contact, visit the study record on ClinicalTrials.gov .